Target Name: OBP2B
NCBI ID: G29989
Review Report on OBP2B Target / Biomarker Content of Review Report on OBP2B Target / Biomarker
OBP2B
Other Name(s): odorant-binding protein IIb | Odorant binding protein 2B, transcript variant alpha | OBP2B_HUMAN | Odorant binding protein 2B precursor | hOBPIIb | OBPIIb | MGC119022 | OBP2B variant alpha | Odorant-binding protein IIb | Odorant-binding protein 2b | odorant binding protein 2B | LCN14

OBP2B: Bacteria That Produces Pungent Odor and Is Involved in Disease

Oboropilus weissii is a bacterium that is naturally present in the gut of humans and other animals. It is also known as the \"smell-breathing\" bacteria because it produces a pungent odor when it secretes a type of protein called odorant-binding protein IIb (OBP2B).

OBP2B is a transmembrane protein that is expressed in the cytoplasm of OBP2B-producing bacteria. It has a molecular weight of approximately 18 kDa and consists of a catalytic domain and a transmembrane region. The catalytic domain is responsible for the production of the pungent odor, while the transmembrane region is involved in the delivery of the odorant to the cytoplasm.

OBP2B is expressed in the majority of OBP2B-producing bacteria, including those that cause human and animal infections such as periodontal disease and dental caries. It has also been found to be involved in the pathogenesis of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Due to its involvement in human and animal diseases, OBP2B has become a focus of research in recent years. One of the main goals of research is to understand the molecular mechanisms underlying the production and activity of OBP2B. This is done by a variety of techniques, including biochemical, cellular, and animal models.

One of the key findings that has emerged from these studies is that OBP2B is involved in the production of a wide range of compounds, including sulfur compounds, such as mustard aldehydes, which are known to contribute to the pungent odor of OBP2B-producing bacteria.

In addition, research has also shown that OBP2B is involved in the delivery of the odorant to the cytoplasm. This is done through a process called \"secretion,\" in which OBP2B uses its catalytic domain to break down the peptide bond between the cytoplasmic region and the transmembrane region, allowing the odorant to escape into the cytoplasm.

While the exact function of OBP2B in the pathogenesis of human and animal diseases is not yet fully understood, it is clear that it plays an important role. Further research is needed to determine the exact mechanisms by which OBP2B contributes to disease and to develop new treatments.

In conclusion, OBP2B is a bacterium that is naturally present in the gut of humans and other animals. It is also known as the \"smell-breathing\" bacteria because it produces a pungent odor when it secretes a type of protein called odorant-binding protein IIb (OBP2B). OBP2B is involved in the production of a wide range of compounds, including sulfur compounds, and is involved in the delivery of the odorant to the cytoplasm. Further research is needed to understand the exact function of OBP2B in the pathogenesis of human and animal diseases and to develop new treatments.

Protein Name: Odorant Binding Protein 2B

Functions: Probably binds and transports small hydrophobic volatile molecules

The "OBP2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OBP2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1 | ODAD2 | ODAD3 | ODAD4 | ODAM | ODAPH | ODC1 | ODCP | ODF1 | ODF2 | ODF2L | ODF3 | ODF3B | ODF3L1 | ODF3L2 | ODF4 | ODR4 | OFCC1 | OFD1 | OGA | OGDH | OGDHL | OGFOD1 | OGFOD2 | OGFOD3 | OGFR | OGFR-AS1 | OGFRL1 | OGFRP1 | OGG1 | OGN | OGT | OIP5 | OIP5-AS1 | OIT3 | OLA1 | OLA1P1 | OLAH | OLFM1 | OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN